title: New directions in anticoagulation.
authors.forename: Joseph S
authors.initials: JS
authors.lastname: Alpert
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D000069604:Dabigatran; D006801:Humans; D009025:Morpholines / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000517:prevention & control; D011720:Pyrazoles / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D011728:Pyridones / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D000069552:Rivaroxaban; D020521:Stroke / Q000517:prevention & control*; D013876:Thiophenes / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D014859:Warfarin / Q000627:therapeutic use; D015091:beta-Alanine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D009025:Morpholines; D011720:Pyrazoles; D011728:Pyridones; D013876:Thiophenes; D015091:beta-Alanine; C522181:apixaban; D014859:Warfarin; D000069552:Rivaroxaban; D000069604:Dabigatran